Position in NVS
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$1,572,998
-$75,785 QoQ
Shares Held
10,037
-7.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#488
of 1,603 holders
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Apollon Wealth Management, LLC holds $214,410,726 across 14 Drug Manufacturers - General names. NVS ranks #11 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
67,842 | $81,371,736 | |
| 2 | JNJ |
Johnson & Johnson
|
161,278 | $40,959,773 | |
| 3 | ABBV |
AbbVie Inc.
|
122,381 | $30,795,954 | |
| 4 | AZN |
Astrazeneca PLC
|
97,297 | $18,449,457 | |
| 5 | MRK |
Merck & Co., Inc.
|
96,041 | $12,341,268 | |
| 6 | AMGN |
Amgen Inc
|
23,363 | $8,460,209 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
104,485 | $6,020,425 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
38,585 | $4,874,828 |
All Filings in NVS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,572,998 | 10,037 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $1,648,783 | 10,794 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $1,440,879 | 10,451 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $1,383,837 | 10,791 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $1,313,563 | 10,855 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $1,198,521 | 10,751 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $1,152,636 | 11,845 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $1,255,903 | 10,919 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $1,215,027 | 11,413 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $1,257,006 | 12,995 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $1,317,658 | 13,050 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $515,411 | 5,060 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $483,056 | 4,787 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $365,056 | 3,968 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $370,681 | 4,086 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $424,287 | 5,582 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $333,386 | 3,944 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $456,475 | 5,202 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $903,477 | 10,329 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $352,962 | 4,316 | Shares | Sole | 2021-11-15 | |
| 2020-06-30 | $960 | 11 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||